Empowering Healthcare Providers with Proactive Risk Intelligence
Mezra.ai is an AI-powered company that proactively identifies and manages opioid and benzodiazepine-related prescribing risks for healthcare practices and systems.
Mezra.ai Utilizes Continuous Process Improvement
Risks and potential harm extend far beyond simply the prescribing of high doses of opioids because oversight is more than a simple dashboard.
Identify Significant Issues & Track until Resolved
Engage and Educate Prescribers on Best Practice
Document All Communications & Recommendations
Monthly Audit-Ready Summaries for Risk, Quality & Legal Teams
What We Address
Patients on high-dose opioids
Lack of tapering or supporting documentation
Missing naloxone prescribing
Failure to check PDMP when required
Concurrent opioid/benzo prescribing
Multi-pharmacy/multi-prescribe
Opioid therapy without needed documentation
Patients due for urine drug screening
Lock of in-office follow-up
No Opioid contracts when indicated
Proactive oversight reduces risk of avoidable harm and mitigates organizational risk
Prevent what are often silent failures
Decrease malpractice exposure
Avoid difficult medical staff issues
Increase patient safety and the quality of healthcare
Prepare for Joint Commission, CMS, State, or DEA scrutiny
Support overburdened clinicians with clear evidence-based guidance
Avoid the sudden and stressful "why didn't we know that?" finger pointing
Support and align with culture of safety and high reliability
Provide clear documentation of oversight and actions taken